With the rising incidence of cancer in India, AstraZeneca India's breast cancer medicine trastuzumab deruxtecan (sold under ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and ...

Sensex, Nifty extended their losing streak for the fourth consecutive session on February 10, as fresh concerns over US ...

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Shares in Sun Pharma fell sharply after the NSE filing as investors reacted to the news. The drugmaker has previously said that it hopes to achieve $200 million in annual sales from the drug ...

Among them, the cardiac, anti-diabetic, and gastrointestinal therapies saw high value growth of 10.9 per cent, 10.2 per cent, ...

Melbourne billionaire Dennis Bastas has responded to rumours denying his purchase of a Toorak estate that sold for a national house price record for as much as $150m.

In other trial news, genetic medicine house PYC Therapeutics (ASX:PYC) has been given the go-ahead to start a local trial of ...

Sun Pharmaceutical Industries Ltd. closed 13.60% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...